Saturday, May 14, 2011 11:39:52 PM
By Zacks Investment Research Feb 14, 2011, 11:58 AM Author's Website
Zynex Inc.’s (ZYXI) stock was seriously punished with the April 2009 restatement announcement and, despite revenue growth of almost 60% in 2009 and 30% through the first nine months of 2010, has yet to fully recover. Until there is resolution on what we would characterize as “significant” lingering concerns (most notably the outstanding lawsuit and ongoing refund claims by Anthem), we believe Zynex’s stock will continue to trade at a significant discount. Complete insider control and thin float also generally penalizes valuation – as Zynex’s CEO owns 60% of the outstanding shares, we also expect this to continue to weigh on the share price.
We are also concerned about the current absence of a definitive and significant catalyst to propel long-term revenue growth. Zynex’s recent strategy of recruiting competitors’ sales reps may not be sustainable for more than a few more years, especially if larger competitors increase commissions to their reps in order to stem their sales force attrition and the resultant market share losses to Zynex. The new businesses (Monitoring and NeuroDiagnostics) may indeed evolve into very meaningful contributors to and drivers of long-term revenue growth. But until there are more specifics on the products expected to be developed through these businesses and plans relative to R&D strategies and efforts, it is impossible to comfortably gauge the viability of management’s expectations for these units or their potential financial contribution.
Recent ZYXI News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/05/2024 10:53:47 PM
- Zynex to Present at the HC Wainwright Global Investment Conference • PR Newswire (US) • 09/04/2024 01:15:00 PM
- Zynex Obtains FDA clearance for new Pain Management Device • PR Newswire (US) • 09/03/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 11:05:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 10:25:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 10:24:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 10:24:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 10:23:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/30/2024 01:00:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/25/2024 09:00:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/25/2024 08:15:23 PM
- Zynex Reports Second Quarter 2024 Financial Results • PR Newswire (US) • 07/25/2024 08:01:00 PM
- Zynex Sets Second Quarter 2024 Earnings Call • PR Newswire (US) • 07/17/2024 01:15:00 PM
- Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces • PR Newswire (US) • 07/11/2024 01:15:00 PM
- Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 • PR Newswire (US) • 06/10/2024 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 10:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 09:00:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/16/2024 09:24:18 PM
- Zynex to Present at the RBC Capital Markets Global Healthcare Conference • PR Newswire (US) • 05/09/2024 01:15:00 PM
- Zynex Executives Recognized Among Top 25 in Medical Technology • PR Newswire (US) • 05/07/2024 01:15:00 PM
- Zynex Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/30/2024 08:01:00 PM
- Zynex Sets First Quarter 2024 Earnings Call • PR Newswire (US) • 04/18/2024 01:15:00 PM
- Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award • PR Newswire (US) • 04/02/2024 01:15:00 PM
FEATURED Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM
Element79 Gold Corp Announces 2024 Clover Work Plans & Nevada Portfolio Updates • ELMGF • Sep 10, 2024 11:00 AM